Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

845 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Standardised and hierarchically classified heart failure and complementary disease monitoring outcome measures: european Unified Registries for heart Care evaluation and randomised trials (EuroHeart).
Bhatty A, Wilkinson C, Batra G, Aktaa S, Smith AB, Wahab A, Chappell S, Alfredsson J, Erlinge D, Ferreira J, Guðmundsdóttir IJ, Hrafnkelsdóttir ÞJ, Ingimarsdóttir IJ, Irs A, Jánosi A, Járai Z, Oliveira-Santos M, Popescu BA, Vasko P, Vinereanu D, Yap J, Bugiardini R, Cenko E, Nadarajah R, Sydes MR, James S, Maggioni AP, Wallentin L, Casadei B, Gale CP. Bhatty A, et al. Among authors: wallentin l. Eur Heart J Qual Care Clin Outcomes. 2024 Oct 9:qcae086. doi: 10.1093/ehjqcco/qcae086. Online ahead of print. Eur Heart J Qual Care Clin Outcomes. 2024. PMID: 39384575
Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST-elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy.
James SK, Siegbahn A, Armstrong P, Barnathan E, Califf R, Simoons ML, Wallentin L. James SK, et al. Among authors: wallentin l. Am Heart J. 2004 Feb;147(2):267-74. doi: 10.1016/j.ahj.2003.09.014. Am Heart J. 2004. PMID: 14760324 Clinical Trial.
Natriuretic peptides in unstable coronary artery disease.
Jernberg T, James S, Lindahl B, Johnston N, Stridsberg M, Venge P, Wallentin L. Jernberg T, et al. Among authors: wallentin l. Eur Heart J. 2004 Sep;25(17):1486-93. doi: 10.1016/j.ehj.2004.06.017. Eur Heart J. 2004. PMID: 15342167 Review.
NT-ProBNP in non-ST-elevation acute coronary syndrome.
Jernberg T, James S, Lindahl B, Stridsberg M, Venge P, Wallentin L. Jernberg T, et al. Among authors: wallentin l. J Card Fail. 2005 Jun;11(5 Suppl):S54-8. doi: 10.1016/j.cardfail.2005.04.010. J Card Fail. 2005. PMID: 15948102 Review.
Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease.
Wallentin L, Varenhorst C, James S, Erlinge D, Braun OO, Jakubowski JA, Sugidachi A, Winters KJ, Siegbahn A. Wallentin L, et al. Eur Heart J. 2008 Jan;29(1):21-30. doi: 10.1093/eurheartj/ehm545. Epub 2007 Nov 30. Eur Heart J. 2008. PMID: 18055486 Clinical Trial.
845 results